Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
173
2.660
 Why?
HIV Infections
27
2022
3154
1.640
 Why?
Antiretroviral Therapy, Highly Active
9
2017
278
1.610
 Why?
Pneumococcal Vaccines
5
2021
130
1.580
 Why?
Antiviral Agents
12
2024
767
1.370
 Why?
Pregnancy Complications, Infectious
14
2015
428
1.290
 Why?
Enterovirus
9
2019
82
1.130
 Why?
Hematopoietic Stem Cell Transplantation
4
2021
675
0.930
 Why?
Immunologic Memory
3
2013
366
0.900
 Why?
Pneumococcal Infections
3
2013
103
0.870
 Why?
Immunization, Secondary
4
2021
91
0.860
 Why?
Oxadiazoles
4
2015
37
0.790
 Why?
Paralysis
4
2018
67
0.700
 Why?
Child
56
2024
22633
0.620
 Why?
Triazoles
3
2024
184
0.590
 Why?
Sinusitis
7
2013
228
0.550
 Why?
Mucositis
1
2018
20
0.550
 Why?
Anti-Retroviral Agents
8
2022
250
0.540
 Why?
Vaccination
4
2017
1423
0.530
 Why?
Meningoencephalitis
1
2017
24
0.530
 Why?
Candidiasis, Invasive
3
2024
6
0.520
 Why?
Antibodies, Bacterial
4
2013
148
0.520
 Why?
Myelitis
4
2019
107
0.510
 Why?
Influenza, Human
5
2015
616
0.510
 Why?
Theilovirus
4
2000
4
0.500
 Why?
Encephalitis
1
2017
139
0.470
 Why?
Influenza A Virus, H1N1 Subtype
3
2015
157
0.470
 Why?
Graft vs Host Disease
1
2018
264
0.470
 Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.450
 Why?
Neonatal Sepsis
1
2015
8
0.450
 Why?
Immunocompromised Host
5
2021
201
0.450
 Why?
Central Nervous System Viral Diseases
4
2019
78
0.440
 Why?
Herpes Simplex
4
2017
98
0.430
 Why?
Influenza Vaccines
3
2015
529
0.430
 Why?
Antifungal Agents
5
2024
149
0.430
 Why?
Disease Outbreaks
6
2019
422
0.420
 Why?
Neuromyelitis Optica
1
2015
138
0.390
 Why?
CD4 Lymphocyte Count
8
2022
277
0.390
 Why?
Placenta
6
2000
780
0.390
 Why?
Adolescent
37
2024
22428
0.380
 Why?
Child, Preschool
28
2024
11787
0.380
 Why?
Humans
89
2024
144759
0.370
 Why?
Measles Vaccine
1
2012
19
0.370
 Why?
Drug Discovery
1
2013
155
0.370
 Why?
Infant, Newborn
25
2018
6429
0.370
 Why?
Neuromuscular Diseases
3
2019
146
0.370
 Why?
Infant
27
2024
10034
0.370
 Why?
Mucormycosis
3
2005
19
0.360
 Why?
RNA, Viral
12
2013
688
0.340
 Why?
Meningococcal Vaccines
2
2012
58
0.330
 Why?
Cardiovirus Infections
2
2000
3
0.330
 Why?
Female
62
2024
78271
0.320
 Why?
Male
53
2024
72315
0.320
 Why?
Viral Vaccines
2
2009
107
0.310
 Why?
Candidemia
2
2023
15
0.310
 Why?
Oxazoles
4
2015
48
0.310
 Why?
Anti-HIV Agents
5
2022
888
0.300
 Why?
Hepatitis B Vaccines
1
2009
43
0.300
 Why?
Viral Load
7
2017
526
0.300
 Why?
AIDS-Related Opportunistic Infections
3
2015
130
0.290
 Why?
Bacterial Vaccines
1
2009
63
0.280
 Why?
Fatigue Syndrome, Chronic
1
2008
19
0.270
 Why?
Pertussis Vaccine
1
2007
24
0.270
 Why?
Communicable Diseases, Emerging
1
2008
38
0.260
 Why?
Poliomyelitis
2
1997
35
0.260
 Why?
Mycetoma
2
2004
6
0.250
 Why?
Immunoglobulins, Intravenous
3
1997
126
0.250
 Why?
Viremia
5
2021
158
0.240
 Why?
Rhinitis
3
2009
171
0.240
 Why?
Fetus
3
2000
803
0.240
 Why?
Antibodies, Viral
5
2022
672
0.210
 Why?
Pregnancy
16
2021
7190
0.210
 Why?
Enterovirus B, Human
3
2001
25
0.210
 Why?
Meningitis, Viral
2
2004
20
0.210
 Why?
Maxillary Sinusitis
2
2004
6
0.210
 Why?
Maus Elberfeld virus
3
1993
5
0.200
 Why?
Anti-Bacterial Agents
3
2013
1907
0.200
 Why?
Cytomegalovirus
2
2016
168
0.200
 Why?
Acquired Immunodeficiency Syndrome
2
2017
235
0.190
 Why?
Interferon-gamma
2
2015
784
0.190
 Why?
Global Health
2
2018
401
0.190
 Why?
Placenta Diseases
2
1995
19
0.180
 Why?
Administration, Intravenous
2
2024
170
0.180
 Why?
Centralized Hospital Services
1
2001
6
0.180
 Why?
Pneumonia, Viral
2
2021
384
0.180
 Why?
Oseltamivir
2
2012
14
0.170
 Why?
Hepatitis, Viral, Human
1
2001
20
0.170
 Why?
Fetal Diseases
3
2000
191
0.170
 Why?
Research Support as Topic
1
2001
80
0.170
 Why?
Colorado
7
2021
4564
0.160
 Why?
United States
13
2021
15966
0.160
 Why?
Ethmoid Sinusitis
1
1999
1
0.160
 Why?
Streptococcus pneumoniae
3
2014
177
0.150
 Why?
Hydrops Fetalis
1
1999
13
0.150
 Why?
Uterine Diseases
1
1999
18
0.150
 Why?
Retrospective Studies
14
2022
17066
0.150
 Why?
Intracranial Hemorrhages
1
2000
100
0.150
 Why?
Drug Resistance, Microbial
1
1999
69
0.150
 Why?
Embryonic Development
1
2000
125
0.150
 Why?
Polymerase Chain Reaction
4
2016
1054
0.150
 Why?
Blood Coagulation Disorders
1
2001
189
0.150
 Why?
Antibodies, Neutralizing
3
2022
340
0.150
 Why?
Biliary Atresia
1
2020
158
0.140
 Why?
Mastoiditis
2
2014
10
0.140
 Why?
Young Adult
14
2017
14105
0.140
 Why?
Treatment Outcome
10
2024
11679
0.140
 Why?
Follow-Up Studies
8
2022
5408
0.140
 Why?
Nervous System Diseases
2
2019
284
0.140
 Why?
Enterovirus D, Human
2
2018
87
0.140
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
13
0.140
 Why?
Fluoxetine
1
2018
54
0.140
 Why?
Risk Factors
12
2024
10779
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
851
0.140
 Why?
Arboviruses
1
2017
14
0.130
 Why?
Hospitals, Pediatric
1
2001
556
0.130
 Why?
Neurodevelopmental Disorders
1
2021
227
0.130
 Why?
Nucleic Acid Hybridization
6
1991
187
0.130
 Why?
In Situ Hybridization
4
2000
319
0.130
 Why?
Double-Blind Method
3
2015
2029
0.130
 Why?
Acyclovir
2
2015
96
0.130
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
HIV-1
2
2015
896
0.130
 Why?
Allografts
1
2018
150
0.130
 Why?
Antibodies, Monoclonal
2
2022
1519
0.130
 Why?
Sexual Maturation
1
2017
51
0.130
 Why?
Cohort Studies
7
2024
5960
0.130
 Why?
Immunization, Passive
1
1997
87
0.130
 Why?
Endoscopy
1
1999
316
0.130
 Why?
Practice Guidelines as Topic
2
2022
1560
0.120
 Why?
Cytomegalovirus Retinitis
1
2016
22
0.120
 Why?
Clinical Trials as Topic
1
2001
1053
0.120
 Why?
Brain
3
2017
2933
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Hyperlipidemias
1
2017
122
0.120
 Why?
DNA, Viral
2
2016
358
0.120
 Why?
Gastrointestinal Diseases
1
2018
216
0.120
 Why?
Diagnosis, Differential
2
2017
1489
0.120
 Why?
Nasal Mucosa
2
2009
112
0.120
 Why?
Mice, Inbred ICR
4
1997
113
0.120
 Why?
Postoperative Complications
2
2016
2919
0.110
 Why?
Congenital Abnormalities
2
2010
104
0.110
 Why?
Lymphocyte Subsets
1
2015
83
0.110
 Why?
Sexually Transmitted Diseases
1
2017
166
0.110
 Why?
Respiratory Syncytial Virus Infections
1
1997
136
0.110
 Why?
Chi-Square Distribution
2
2013
529
0.110
 Why?
Ganciclovir
1
2015
53
0.110
 Why?
Child Development
2
2017
484
0.110
 Why?
Muscle Hypotonia
1
2015
33
0.110
 Why?
Lymphopenia
1
2015
65
0.110
 Why?
Oropharynx
1
2015
46
0.110
 Why?
Cranial Nerve Diseases
1
2015
43
0.110
 Why?
Adenovirus Infections, Human
2
1991
15
0.110
 Why?
Incidence
6
2017
2879
0.110
 Why?
Adult
17
2022
40449
0.110
 Why?
Hearing Loss, Sensorineural
1
2015
73
0.100
 Why?
Beclomethasone
1
1993
8
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Rectum
1
2015
180
0.100
 Why?
Mycoses
1
2014
88
0.100
 Why?
Antibody Affinity
1
2013
60
0.100
 Why?
Giant Cells
1
1993
21
0.100
 Why?
Hemagglutination Inhibition Tests
1
2013
38
0.100
 Why?
Liver Transplantation
1
2020
823
0.100
 Why?
Cytomegalovirus Infections
1
2015
206
0.100
 Why?
Chickenpox
1
1993
81
0.090
 Why?
Candida
1
2012
44
0.090
 Why?
Intensive Care Units, Pediatric
1
2015
285
0.090
 Why?
Viral Plaque Assay
1
2012
29
0.090
 Why?
Orthomyxoviridae
1
2012
40
0.090
 Why?
Hospital Design and Construction
1
1992
3
0.090
 Why?
Neutralization Tests
1
2012
76
0.090
 Why?
Aircraft
1
1992
23
0.090
 Why?
CD4-Positive T-Lymphocytes
2
2017
1129
0.090
 Why?
Bacterial Infections
2
2009
246
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
HIV
1
2013
250
0.090
 Why?
Drug Resistance, Viral
1
2012
122
0.090
 Why?
Severity of Illness Index
4
2021
2925
0.090
 Why?
Chlamydia trachomatis
1
1991
49
0.090
 Why?
Gestational Age
4
2015
975
0.090
 Why?
Chorioamnionitis
1
1991
45
0.080
 Why?
Peritoneovenous Shunt
1
1990
1
0.080
 Why?
Maternal-Fetal Exchange
2
2007
169
0.080
 Why?
Meningitis, Aseptic
1
1990
13
0.080
 Why?
Decision Support Techniques
1
2015
456
0.080
 Why?
Poliovirus Vaccine, Oral
1
1990
25
0.080
 Why?
Trophoblasts
1
1993
216
0.080
 Why?
Rimantadine
1
2010
1
0.080
 Why?
Prospective Studies
7
2017
7990
0.080
 Why?
Legionnaires' Disease
1
1990
4
0.080
 Why?
Adamantane
1
2010
17
0.080
 Why?
Poliovirus
1
1990
73
0.080
 Why?
Hepatitis B Antibodies
1
2009
6
0.080
 Why?
Biomarkers
1
2021
4271
0.080
 Why?
Cross Infection
1
1992
262
0.070
 Why?
Meningitis
1
1990
80
0.070
 Why?
T-Lymphocytes
2
2015
1982
0.070
 Why?
Respiratory Tract Infections
3
2016
397
0.070
 Why?
Administration, Oral
3
2012
847
0.070
 Why?
Maxillary Sinus
2
2009
11
0.070
 Why?
Mice
8
2000
18339
0.070
 Why?
Age Factors
4
2017
3333
0.070
 Why?
Mucor
2
2005
6
0.070
 Why?
South Africa
1
2009
261
0.070
 Why?
Evidence-Based Medicine
3
2021
732
0.070
 Why?
Drug Administration Schedule
2
2015
779
0.070
 Why?
Body Fluids
1
1987
70
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.060
 Why?
Aspergillosis
2
2014
23
0.060
 Why?
Acute Kidney Injury
1
2015
865
0.060
 Why?
Virus Diseases
1
2009
216
0.060
 Why?
Mitochondrial Diseases
1
2007
93
0.060
 Why?
Zygomycosis
1
2006
6
0.060
 Why?
Carotid Artery Thrombosis
1
2005
6
0.060
 Why?
Organ Transplantation
1
2009
247
0.060
 Why?
Statistics as Topic
1
2006
284
0.060
 Why?
Chronic Disease
5
2009
1813
0.060
 Why?
Logistic Models
2
2023
2117
0.060
 Why?
Antibodies, Monoclonal, Humanized
2
2022
985
0.060
 Why?
Drug Therapy, Combination
2
2007
1047
0.060
 Why?
International Cooperation
2
2018
198
0.050
 Why?
Scedosporium
1
2004
1
0.050
 Why?
Herpesvirus 7, Human
1
2004
6
0.050
 Why?
Drug Resistance, Fungal
1
2004
7
0.050
 Why?
Roseolovirus Infections
1
2004
8
0.050
 Why?
Herpesvirus 6, Human
1
2004
14
0.050
 Why?
Longitudinal Studies
3
2018
2947
0.050
 Why?
Animals
9
2000
38058
0.050
 Why?
Granulocyte Colony-Stimulating Factor
1
2004
89
0.050
 Why?
Respiratory Syncytial Viruses
2
1997
58
0.050
 Why?
Randomized Controlled Trials as Topic
2
2004
1720
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
161
0.050
 Why?
Vaccines, Conjugate
2
2014
60
0.050
 Why?
Infant, Premature, Diseases
2
1997
111
0.050
 Why?
Biological Availability
1
2003
142
0.050
 Why?
Risk Assessment
2
2020
3671
0.050
 Why?
Probability
1
2003
310
0.050
 Why?
Growth Disorders
1
2022
86
0.040
 Why?
Reference Values
1
2003
797
0.040
 Why?
Bacteria, Aerobic
1
2001
7
0.040
 Why?
Case-Control Studies
3
2015
3604
0.040
 Why?
Personnel Staffing and Scheduling
1
2001
98
0.040
 Why?
Disease Models, Animal
3
2000
4557
0.040
 Why?
Drug Combinations
1
2022
390
0.040
 Why?
Income
1
2022
202
0.040
 Why?
Drug Approval
1
2021
89
0.040
 Why?
RNA Probes
2
1991
12
0.040
 Why?
Disseminated Intravascular Coagulation
1
2000
32
0.040
 Why?
United States Food and Drug Administration
1
2021
203
0.040
 Why?
Adenosine Monophosphate
1
2021
86
0.040
 Why?
Systemic Inflammatory Response Syndrome
1
2021
96
0.040
 Why?
Prenatal Exposure Delayed Effects
1
2007
675
0.040
 Why?
RNA
2
2022
940
0.040
 Why?
Alanine
1
2021
171
0.040
 Why?
Necrosis
1
2000
244
0.040
 Why?
Remission Induction
1
2020
307
0.040
 Why?
Picornaviridae Infections
2
1990
50
0.040
 Why?
Otitis Media with Effusion
1
1999
20
0.040
 Why?
Amniotic Fluid
2
1991
79
0.040
 Why?
Cerebrospinal Fluid
2
2004
88
0.040
 Why?
Pharyngitis
1
1999
25
0.040
 Why?
Pseudallescheria
1
1999
3
0.040
 Why?
Fungi
2
2014
161
0.040
 Why?
Zidovudine
2
2010
77
0.040
 Why?
Opportunistic Infections
1
1999
45
0.040
 Why?
Dose-Response Relationship, Drug
1
2003
2027
0.040
 Why?
Time Factors
1
2009
7173
0.030
 Why?
Living Donors
1
2020
280
0.030
 Why?
Spinal Cord
1
2000
380
0.030
 Why?
Chlamydiaceae Infections
1
2017
1
0.030
 Why?
Diabetes Mellitus, Type 1
2
2005
3890
0.030
 Why?
Epidemiological Monitoring
1
2018
69
0.030
 Why?
Nutrition Disorders
1
1997
20
0.030
 Why?
Internationality
1
2018
156
0.030
 Why?
Sex Factors
2
2017
2112
0.030
 Why?
B-Lymphocytes
2
2015
876
0.030
 Why?
Abortion, Spontaneous
1
1997
115
0.030
 Why?
Antigens, Viral
1
2017
182
0.030
 Why?
Ophthalmoscopy
1
2016
38
0.030
 Why?
Heart
1
2000
636
0.030
 Why?
Reoperation
1
1999
630
0.030
 Why?
Otitis Media
1
1999
181
0.030
 Why?
Encephalomyelitis
1
2016
14
0.030
 Why?
Plasma Cells
2
2009
75
0.030
 Why?
Tissue and Organ Procurement
1
2020
346
0.030
 Why?
Acute Disease
1
1999
1030
0.030
 Why?
Enzyme-Linked Immunospot Assay
1
2015
37
0.030
 Why?
Immune Tolerance
2
1999
379
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Molecular Diagnostic Techniques
1
2016
104
0.030
 Why?
Transplantation, Homologous
1
2016
415
0.030
 Why?
Caribbean Region
1
2015
30
0.030
 Why?
Multicenter Studies as Topic
1
1997
405
0.030
 Why?
North America
1
2016
310
0.030
 Why?
Encephalitis, Varicella Zoster
1
2015
16
0.030
 Why?
Biopsy
3
2009
1075
0.030
 Why?
Encephalitis, Herpes Simplex
1
2015
21
0.030
 Why?
Audiometry
1
2015
35
0.030
 Why?
Patient Outcome Assessment
1
2016
134
0.030
 Why?
Physical Conditioning, Animal
1
1997
243
0.030
 Why?
Latin America
1
2015
94
0.030
 Why?
Evaluation Studies as Topic
1
1995
166
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Odds Ratio
1
2017
1075
0.030
 Why?
C-Reactive Protein
1
2017
416
0.030
 Why?
Hematologic Neoplasms
1
2016
161
0.030
 Why?
Coinfection
1
2016
141
0.030
 Why?
Microscopy, Electron
1
1995
415
0.030
 Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
50
0.030
 Why?
Canada
1
2015
428
0.030
 Why?
Combined Modality Therapy
3
2005
1266
0.030
 Why?
Neutropenia
1
2015
155
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Infusions, Intravenous
1
2015
423
0.030
 Why?
Multivariate Analysis
1
2017
1539
0.030
 Why?
Papillomavirus Vaccines
1
2017
297
0.020
 Why?
Administration, Intranasal
1
1993
93
0.020
 Why?
Sexual Behavior
1
2017
491
0.020
 Why?
Papillomavirus Infections
1
2017
345
0.020
 Why?
Sequence Analysis, DNA
1
2016
824
0.020
 Why?
T-Lymphocyte Subsets
1
2015
415
0.020
 Why?
Mortality
1
2015
375
0.020
 Why?
Epidemiologic Studies
1
2012
68
0.020
 Why?
Prognosis
1
2001
4282
0.020
 Why?
Oncology Service, Hospital
1
1992
15
0.020
 Why?
Electromyography
1
2015
415
0.020
 Why?
Neisseria meningitidis
1
2012
23
0.020
 Why?
Pandemics
1
2021
1694
0.020
 Why?
Meningococcal Infections
1
2012
26
0.020
 Why?
Infant, Premature
1
1997
611
0.020
 Why?
Tomography, X-Ray Computed
2
1999
2730
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Ventilation
1
1992
46
0.020
 Why?
Amniocentesis
1
1991
20
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Microbial Viability
1
2012
90
0.020
 Why?
Europe
1
2012
412
0.020
 Why?
Flow Cytometry
1
2015
1173
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Lymphocyte Activation
1
2015
1126
0.020
 Why?
Respirovirus Infections
1
1990
14
0.020
 Why?
Anti-Infective Agents
1
2013
242
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Comorbidity
1
2016
1658
0.020
 Why?
Aged, 80 and over
1
2023
8265
0.020
 Why?
Immunohistochemistry
1
1995
1716
0.020
 Why?
Chlamydia Infections
1
1991
81
0.020
 Why?
Benzoxazines
1
2010
31
0.020
 Why?
Rhinovirus
1
1990
57
0.020
 Why?
Cyclopropanes
1
2010
83
0.020
 Why?
Legionella
1
1990
9
0.020
 Why?
Alkynes
1
2010
66
0.020
 Why?
Population Surveillance
1
1993
485
0.020
 Why?
Sensitivity and Specificity
1
1995
1985
0.020
 Why?
Cells, Cultured
1
1997
4154
0.020
 Why?
Leukemia
1
1992
245
0.020
 Why?
Dermatomyositis
1
1989
24
0.020
 Why?
Inpatients
1
2014
545
0.020
 Why?
Hospitals
1
2014
730
0.020
 Why?
Peroxidase
1
2009
168
0.020
 Why?
Staining and Labeling
1
2009
151
0.020
 Why?
Natural Killer T-Cells
1
2009
67
0.020
 Why?
Muscles
1
1989
333
0.020
 Why?
Magnetic Resonance Imaging
2
2015
3863
0.020
 Why?
Respiratory Tract Diseases
1
1990
175
0.020
 Why?
Picornaviridae
1
1988
18
0.020
 Why?
Seasons
1
1990
556
0.020
 Why?
Ribonucleases
1
1987
49
0.020
 Why?
Central Nervous System
1
2010
281
0.020
 Why?
HIV Reverse Transcriptase
1
2007
31
0.020
 Why?
Lamivudine
1
2007
65
0.020
 Why?
Telencephalon
1
2005
16
0.010
 Why?
Cavernous Sinus
1
2005
16
0.010
 Why?
Antigens, CD
1
2009
555
0.010
 Why?
Orbit
1
2005
64
0.010
 Why?
Infectious Disease Transmission, Vertical
1
2007
193
0.010
 Why?
Paranasal Sinuses
1
2005
81
0.010
 Why?
Cross-Sectional Studies
1
2016
5868
0.010
 Why?
Exocrine Glands
1
2004
5
0.010
 Why?
Basement Membrane
1
2004
32
0.010
 Why?
Cell Count
1
2004
320
0.010
 Why?
Prevalence
1
2010
2834
0.010
 Why?
Neutrophils
1
2009
1134
0.010
 Why?
Lymphocytes
1
2004
382
0.010
 Why?
Eosinophils
1
2004
316
0.010
 Why?
Penicillin Resistance
1
2001
8
0.010
 Why?
Macrophages
1
2009
1511
0.010
 Why?
beta-Lactamases
1
2001
51
0.010
 Why?
Staphylococcus
1
2001
74
0.010
 Why?
Drug Resistance, Multiple, Bacterial
1
2001
81
0.010
 Why?
Haemophilus influenzae
1
2001
67
0.010
 Why?
Drug Resistance, Bacterial
1
2001
196
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
37
0.010
 Why?
Steroids
1
1999
160
0.010
 Why?
Recurrence
1
1999
1135
0.010
 Why?
Anti-Inflammatory Agents
1
1999
474
0.010
 Why?
Patient Selection
1
1999
719
0.010
 Why?
RNA, Antisense
1
1988
18
0.000
 Why?
DNA, Recombinant
1
1988
48
0.000
 Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.000
 Why?
Virus Replication
1
1988
529
0.000
 Why?
Aged
1
2006
25913
0.000
 Why?
Middle Aged
1
2006
35875
0.000
 Why?
Cell Line
1
1988
2882
0.000
 Why?
DNA
1
1988
1463
0.000
 Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (408) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)